. Author manuscript; available in PMC: 2013 Oct 28.

Published in final edited form as: J Am Soc Echocardiogr. 2009 Jun 23;22(8):10.1016/j.echo.2009.05.002. doi: 10.1016/j.echo.2009.05.002

Table 2.

Cases of Ergotamine induced valvulopathy

Ergotamine Duration,(study author, ref #)	Valvulopathy	Echocardiographic or pathological findings
20 years (Austin, ref #17)	Mitral regurgitation and stenosis	Thickened mitral valve with restricted mobility
18 months (Flaherty, ref #18)	Mitral regurgitation, aortic insufficiency	Thickened mitral valve
5 years (Wilke, ref #19)	Mitral regurgitation, tricuspid stenosis	Aortic valve thickening, tricuspid valve commissural fusion, mitral valve leaflet thickening